Physical Activity, Benign Prostatic Hyperplasia, and Lower Urinary Tract Symptoms

European Urology

Volumn 53, Issue 6, 2008, Pages 1228-1235

  Parsons, J Kellogg ^a   Kashefi, Carol ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benign prostatic hyperplasia; Exercise; Lower urinary tract symptoms; Metabolic syndrome; Modifiable; Physical activity; Risk factor

Indexed keywords

AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX; ARTICLE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

HUMANS; MALE; MOTOR ACTIVITY; PROSTATIC HYPERPLASIA; PROSTATISM;

EID: 42749095533     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.02.019     Document Type: Article

References (30)

1. Wei J.T., Calhoun E., and Jacobsen S.J. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173 (2005) 1256-1261
2. Parsons J.K., Carter H.B., Partin A.W., Windham B.G., Metter E.J., Ferrucci L., et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab 91 (2006) 2562-2568
3. Kristal A.R., Arnold K.B., Schenk J.M., Neuhouser M.L., Weiss N., Goodman P., et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177 (2007) 1395-1400 quiz 591
4. Gupta A., Gupta S., Pavuk M., and Roehrborn C.G. Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68 (2006) 1198-1205
5. Rohrmann S., Smit E., Giovannucci E., and Platz E.A. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond) 29 (2005) 310-316
6. Joseph M.A., Harlow S.D., Wei J.T., Sarma A.V., Dunn R.L., Taylor J.M., et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol 157 (2003) 906-914
7. Parsons J.K. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178 (2007) 395-401
8. Parsons J.K., Bergstrom J., and Barrett-Connor E. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int 101 (2008) 313-318
9. Rohrmann S., Crespo C.J., Weber J.R., Smit E., Giovannucci E., and Platz E.A. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int 96 (2005) 77-82
10. Gann P.H., Hennekens C.H., Longcope C., Verhoek-Oftedahl W., Grodstein F., and Stampfer M.J. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 26 (1995) 40-49
11. Platz E.A., Kawachi I., Rimm E.B., Colditz G.A., Stampfer M.J., Willett W.C., et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med 158 (1998) 2349-2356
12. Meigs J.B., Mohr B., Barry M.J., Collins M.M., and McKinlay J.B. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54 (2001) 935-944
13. Hong J., Kwon S., Yoon H., Lee H., Lee B., Kim H.H., et al. Risk factors for benign prostatic hyperplasia in South Korean men. Urol Int 76 (2006) 11-19
14. Dal Maso L., Zucchetto A., Tavani A., Montella M., Ramazzotti V., Polesel J., et al. Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer 118 (2006) 2632-2635
15. Lacey Jr. J.V., Deng J., Dosemeci M., Gao Y.T., Mostofi F.K., Sesterhenn I.A., et al. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai. China Int J Epidemiol 30 (2001) 341-349
16. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Levels of evidence and grades of recommendation. 2001 [cited 2008 January 2008]; Available from: http://www.cebm.net/levels_of_evidence.asp#levels.
17. Platz E.A., Rimm E.B., Kawachi I., Colditz G.A., Stampfer M.J., Willett W.C., et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol 149 (1999) 106-115
18. Juni P., Altman D.G., and Egger M. Assessing the quality of randomised controlled trials. In: Egger M., Smith G.D., and Altman D.G. (Eds). Systematic Reviews in Health Care (2001), BMJ Publishing Group, London 87-108
19. Prezioso D., Catuogno C., Galassi P., D'Andrea G., Castello G., and Pirritano D. Life-style in patients with LUTS suggestive of BPH. Eur Urol 40 Suppl 1 (2001) 9-12
20. Rohrmann S., Fallin M.D., Page W.F., Reed T., Partin A.W., Walsh P.C., et al. Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins. Epidemiology 17 (2006) 419-427
21. Rahman N.U., Phonsombat S., Bochinski D., Carrion R.E., Nunes L., and Lue T.F. An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int 100 (2007) 658-663
22. Azadzoi K.M., Yalla S.V., and Siroky M.B. Oxidative stress and neurodegeneration in the ischemic overactive bladder. J Urol 178 (2007) 710-715
23. Sciarra A., Di Silverio F., Salciccia S., Autran Gomez A.M., Gentilucci A., and Gentile V. Inflammation and chronic prostatic diseases: evidence for a link?. Eur Urol 52 (2007) 964-972
24. Kramer G., Mitteregger D., and Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?. Eur Urol 51 (2007) 1202-1216
25. Ponholzer A., Temml C., Obermayr R., and Madersbacher S. Association between lower urinary tract symptoms and erectile dysfunction. Urology 64 (2004) 772-776
26. Thompson I.M., Tangen C.M., Goodman P.J., Probstfield J.L., Moinpour C.M., and Coltman C.A. Erectile dysfunction and subsequent cardiovascular disease. Jama 294 (2005) 2996-3002
27. Kaplan S.A., Gonzalez R.R., and Te A.E. Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction. Eur Urol 51 (2007) 1717-1723
28. Bacon C.G., Mittleman M.A., Kawachi I., Giovannucci E., Glasser D.B., and Rimm E.B. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 139 (2003) 161-168
29. Derby C.A., Mohr B.A., Goldstein I., Feldman H.A., Johannes C.B., and McKinlay J.B. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urology 56 (2000) 302-306
30. Blanker M.H., Groeneveld F.P., Prins A., Bernsen R.M., Bohnen A.M., and Bosch J.L. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int 85 (2000) 665-671